NASDAQ · LNZAW

LanzaTech Global, Inc.

$0.02 -$0.00 (-2.44%) 1D Market open

Key Metrics

$39.30K
Market cap
P/E · TTM
$58.38M
Revenue · TTM
−$44.40M
Net income
EPS · TTM $-22.59
Dividend yield
Free cash flow −$53.62M
Beta · 1Y 1.06
EBITDA · TTM −$53.53M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    The stock moved +56.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 22
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 5
    From its Apr 15 high, the share price fell 36%.

    Peak close $0.02 on Apr 15; trough close $0.01 on Jun 5. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Mar 19
    The stock moved +50.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.01 – $0.08
Avg volume · 20D48.0K
Net cash
Book value / share$24.46
IndustryIndustrial Organic Chemicals
ExchangeNASDAQ
About LanzaTech Global, Inc.
IPO dateFeb 10, 2023
Employees192

LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.00
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -99.2%
Net -76.1%
FCF -91.8%
ROE / ROIC -92.4% · —

Financial Health

Current ratio1.96
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$23.55M

Cash Flow · TTM

Operating CF −$53.02M
Capex −$600.00K
Free cash flow −$53.62M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-14.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings